These highlights do not include all the information needed to use STERILE TALC POWDER safely and effectively. See full prescribing information for STERILE TALC POWDER. STERILE TALC POWDER (talc), for intrapleural use Initial U.S. Approval: 2003 | Sterile Talc [Bryan Corporation] | BioPortfolio

12:25 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Sterile Talc Powder is indicated to decrease the recurrence of malignant pleural effusions in symptomatic patients following maximal drainage of the pleural effusion.

The recommended dose is 5 g, suspended in 50 ml to 100 ml 0.9% Sodium Chloride Injection, USP

Prepare the talc suspension using aseptic technique in an appropriate laminar flow hood as follows:

Step 1. Using a 16 gauge needle attached to a 60-ml LuerLok syringe, draw up 50 ml of 0.9 % Sodium Chloride injection, USP. Vent the talc bottle using a needle. Slowly inject the 50 ml of 0.9% Sodium Chloride Injection, USP into the bottle.

Step 2. Swirl the bottle to disperse the talc powder.

Step 3. Divide the contents of the bottle equally into two 60 ml LuerLok syringes, each attached with a 16 gauge needle, by withdrawing 25 ml of the suspension into each syringe with continuous swirling. Add 0.9% Sodium Chloride Injection, USP to a total volume of 50 ml in each syringe. Draw 10 ml of air into each syringe to the 60 ml mark to serve as a headspace for mixing prior to administration. Each syringe should contain 2.5 g of Sterile Talc Powder in 50 ml of 0.9% Sodium Chloride Injection, USP with an air headspace of 10 ml.

Step 4. Label the syringes with the talc concentration, the expiration date and time, the identity of the patient intended to receive the material, and the following statements:

“SHAKE SYRINGE WELL to resuspend before administration”

“FOR PLEURODESIS ONLY – not for intravenous administration”

Step 5. If not used immediately, store prepared suspension in refrigerator. Discard the prepared suspension if not used within 12 hours.

Prior to administration, continuously agitate the syringes to evenly redisperse the talc and avoid settlement. Immediately prior to administration, vent the 10 ml air headspace from each syringe. Administer the talc suspension through the chest tube according to standard procedures.

5 gram white or off-white to light gray sterile powder for suspension in a single-dose glass bottle.


Acute Pneumonitis and ARDS, including fatal cases, occur with intrapleural talc administration.

Sclerosis of the pleural space may preclude or complicate subsequent ipsilateral surgery and diagnostic procedures. Consider the possible effects of the use of Sterile Talc Powder on future diagnostic and therapeutic procedures prior to administration.

Common adverse reactions observed with intrapleurally-administered talc are fever and pain. Other adverse reactions include dyspnea, arrhythmia, empyema, and acute respiratory distress syndrome.

Pregnancy Category B.

Risk Summary

A reproduction study performed in rabbits at doses up to approximately 5 times the human dose revealed no evidence of teratogenicity. There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Animal Data

Rabbits were administered talc by oral gavage daily during the period of organogenesis at doses of up to 900 mg/kg (approximately 5 times the human dose on a mg/m basis). No significant dose-related toxicity was reported except at maternally toxic doses. In multiple animal studies, intrapleurally administered talc was not absorbed systemically.

Safety and effectiveness have not been established in pediatric patients.

STERILE TALC POWDER is a sclerosing agent for intrapleural administration. STERILE TALC POWDER is white or off-white to light gray, asbestos-free and brucite-free sterile talc powder of controlled particle size. The powder is ≥ 95% hydrated magnesium silicate [MgSiO (OH) molecular weight 379.3]; associated minerals include chlorite (hydrated aluminum and magnesium silicate), dolomite (calcium and magnesium carbonate), calcite (calcium carbonate), and quartz. Talc is insoluble in water.

Talc instilled into the pleural cavity is thought to result in an inflammatory reaction. This reaction can promote adherence of the visceral and parietal pleura, which may prevent reaccumulation of pleural fluid.

Studies on the carcinogenicity of talc have been performed using non-standard designs which prevent firm conclusions on its carcinogenicity. With single intraperitoneal administration to mice at 20 mg and observation for at least 6 months or 4 weekly doses administered intraperitoneally at 25 mg/dose to rats with observation for at least 84 weeks, tumor incidence was not increased. In these studies the talc and its asbestos content were not characterized.

Genotoxicity was tested in cultures of rat pleural mesothelial cells (RPMC) as unscheduled DNA synthesis (UDS) and sister chromatid exchanges (SCEs). None of the talc samples (which were asbestos-free) induced enhancement of UDS or SCEs in treated cultures. No information is available on impairment of fertility in animals by talc.

STERILE TALC POWDER is supplied in a single use 100 ml brown glass bottle, sealed with a gray, 20 mm stopper and covered with a flip-off seal.

NDC 63256-200-05: 5 gram individual bottle packaged in a pouch.

NDC 63256-200-10: Carton of ten (10) 5-gram bottles.

Store the powder at 25°C (77°F); excursions permitted between15°C to 30°C (59°F - 86°F) [see USP Controlled Room Temperature]. Protect against sunlight.

Advise patients to notify their healthcare provider if new or worsening pulmonary symptoms develop [see Warnings and Precautions (5.1)].

Distributed by: Bryan Corporation. Woburn, MA 01801.

Principal Display Panel - Bottle Label

Sterile Talc Powder™

(Talc) Powder

Contains 5 grams of sterile talc per bottle

For Intrapleural AdministrationRefer to the Prescribing Information for dosage and preparation.

Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F - 86°F)[see USP Controlled Room Temperature]. Protect against sunlight.

Distributed By: Bryan Corporation Lot# Woburn, MA 01801 Expired:

Rx Only

Principal Display Panel - Pouch Label

Sterile Talc Powder™ NDC 63256-200-05

(Talc) Powder

Contains 5 grams of sterile talc per bottle 1 Bottle

For Intrapleural AdministrationRefer to the Prescribing Information for dosage and preparation.

Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F - 86°F)[see USP Controlled Room Temperature]. Protects against sunlight.

Distributed By: Bryan Corporation Lot# Woburn, MA 01801 Expired:

Rx Only

Principal Display Panel - Box Label

Sterile Talc Powder™ NDC 63256-200-10

(Talc) Powder

Contains 5 grams of sterile talc per bottle 10 Bottles

For Intrapleural AdministrationRefer to the Prescribing Information for dosage and preparation.

Store at 25°C (77°F); excursions permitted between 15°C to 30°C(59°F - 86°F) [see USP Controlled Room Temperature].

Distributed By: Bryan Corporation Lot# Woburn, MA 01801 Expired:

Rx Only


Bryan Corporation

Active Ingredients


Drugs and Medications [143 Associated Drugs and Medications listed on BioPortfolio]

Lumigan [allergan, inc.]

Lumigan 03

Fomepizole [sandoz inc. ]

Rx only Sterile Caution: Must be diluted prior to use.

Greenglo [hub pharmaceuticals, inc.]

Green Glo (Lissamine Green)

Ful-glo [akorn, inc.]

Fluorescein Sodium Ophthalmic Strips, USP

Zymar [allergan, inc.]


Clinical Trials [303 Associated Clinical Trials listed on BioPortfolio]

Talc in Treating Patients With Malignant Pleural Effusion

RATIONALE: Talc may relieve malignant pleural effusion. It is not yet known whether wet talc is more effective than dry talc in treating patients with malignant pleural effusion. PURPOSE:...

Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management

This is a multicentre randomised controlled trial evaluating global health related quality of life outcomes in patients with malignant pleural effusions. Patients will be randomised to rec...

Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion

This is prospective randomized control trial study. The aim of this study is to evaluate the efficacy of Iodopovidone solution for pleurodesis in palliative malignant pleural effusion (MPE...

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

RATIONALE: Video-assisted surgery to remove part of the tissue layer covering the inside of the chest cavity may be effective in treating pleural effusion and cause less damage to normal t...

Test for Preoperative Skin Preparations

Compare 2 application techniques of ChloraPrep Swabstick--3 swabsticks at once versus 3 swabsticks used one-at-a-time. Hibiclens applied according to the manufacturer's directions. Sterile...

PubMed Articles [259 Associated PubMed Articles listed on BioPortfolio]

The hydrophobic surface state of talc as influenced by aluminum substitution in the tetrahedral layer.

Talc is both an important industrial mineral product recovered by flotation, and also in other cases, a gangue mineral of concern in the flotation of certain sulfide ores, such as the PGM ores from So...

The Hospital and Patient Burden of Indwelling Pleural Catheters: A Retrospective Case Series of 210 Indwelling Pleural Catheter Insertions.

Indwelling pleural catheters (IPC) offer an alternative to talc pleurodesis in recurrent effusion, especially in patients wishing to avoid hospitalization. Two randomized trials have demonstrated redu...

The work of sterile processing departments: An exploratory study using qualitative interviews and a quantitative process database.

The sterile processing of surgical instruments and equipment is an essential part of surgical operations. Although clean instruments prevent infections, little is known about the departments that cond...

Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.

Malignant pleural effusion (MPE) is common and imposes a significant burden on patients and health care providers. Most patients require definitive treatment, such as drainage and chemical pleurodesis...

Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.

Increased access to sterile syringes has been shown to reduce HIV risk among people who inject drugs (PWID). Where syringe services programs (SSPs) are limited, pharmacies are an important sterile syr...

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record